forex,euro,dollar,binary option,btc,usd,oil
ROSEMONT, PA, Feb. 16, 2022 (GLOBE NEWSWIRE) — Medunik USA is pleased to announce that Siklos® (hydroxyurea), previously indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises4, has ...
The post Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients now approved for use in adults appeared first on ForexTV.
The post Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients now approved for use in adults appeared first on Forex news - Binary options.